InsiderTrades.com logo
I was wrong. Dead wrong.
From Porter & Company   |   Ad
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
Here’s the full story for you.
Christopher M. Accettella net worth and biography
  • LinkedIn
  • Phone
  • Website

Christopher Accettella Biography and Net Worth

Portfolio Manager of BlackRock Health Sciences Term Trust
Christopher M. Accettella is the Portfolio Mang. at BlackRock Health Sciences Trust.

What is Christopher M. Accettella's net worth?

The estimated net worth of Christopher M. Accettella is at least $59,991.80 as of January 11th, 2024. Mr. Accettella owns 4,070 shares of BlackRock Health Sciences Term Trust stock worth more than $59,992 as of December 21st. This net worth evaluation does not reflect any other assets that Mr. Accettella may own. Learn More about Christopher M. Accettella's net worth.

How do I contact Christopher M. Accettella?

The corporate mailing address for Mr. Accettella and other BlackRock Health Sciences Term Trust executives is 100 Bellevue Parkway, Wilmington, Delaware 19809. BlackRock Health Sciences Term Trust can also be reached via phone at 212-810-5300. Learn More on Christopher M. Accettella's contact information.

Has Christopher M. Accettella been buying or selling shares of BlackRock Health Sciences Term Trust?

Christopher M. Accettella has not been actively trading shares of BlackRock Health Sciences Term Trust over the course of the past ninety days. Most recently, on Thursday, January 11th, Christopher Accettella bought 1,190 shares of BlackRock Health Sciences Term Trust stock. The stock was acquired at an average cost of $15.17 per share, with a total value of $18,052.30. Following the completion of the transaction, the portfolio manager now directly owns 4,070 shares of the company's stock, valued at $61,741.90. Learn More on Christopher M. Accettella's trading history.

Are insiders buying or selling shares of BlackRock Health Sciences Term Trust?

In the last year, BlackRock Health Sciences Term Trust insiders bought shares 30 times. They purchased a total of 2,344,183 shares worth more than $36,776,473.96. The most recent insider tranaction occured on October, 16th when Major Shareholder Saba Capital Management, L.P. bought 29,795 shares worth more than $471,058.95. Learn More about insider trades at BlackRock Health Sciences Term Trust.

Information on this page was last updated on 10/16/2024.

Christopher M. Accettella Insider Trading History at BlackRock Health Sciences Term Trust

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/11/2024Buy1,190$15.17$18,052.304,070View SEC Filing Icon  
3/17/2023Buy333$15.25$5,078.252,635View SEC Filing Icon  
3/8/2023Buy316$15.87$5,014.922,302View SEC Filing Icon  
2/4/2022Buy1,800$21.86$39,348.00View SEC Filing Icon  
See Full Table

Christopher M. Accettella Buying and Selling Activity at BlackRock Health Sciences Term Trust

This chart shows Christopher Accettella's buying and selling at BlackRock Health Sciences Term Trust by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

BlackRock Health Sciences Term Trust Company Overview

BlackRock Health Sciences Term Trust logo
BlackRock Health Sciences Trust II's (BMEZ) (the 'Trust') investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries. The Trust utilizes an option writing (selling) strategy in an effort to generate current gains from options premiums and to enhance the Trust's risk-adjusted returns.
Read More

Today's Range

Now: $14.74
Low: $14.52
High: $14.94

50 Day Range

MA: $15.53
Low: $14.64
High: $16.03

2 Week Range

Now: $14.74
Low: $14.38
High: $16.59

Volume

409,371 shs

Average Volume

280,148 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

6.94%

Beta

N/A
Most People Are Dead Wrong.
From Brownstone Research   |   Ad
Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines about artificial intelligence. Everyone's talking about AI right now. But see, I've been talking about it for years.
I call it my AI Retirement Playbook. I recommend you check it out now.